Indirect stimulation of human Vγ2Vδ2 T cells through alterations in isoprenoid metabolism.

Division of Immunology, Department of Internal Medicine, Interdisciplinary Graduate Program in Immunology, University of Iowa Carver College of Medicine, Veterans Affairs Medical Center, Iowa City, IA 52242, USA.
The Journal of Immunology (Impact Factor: 5.36). 11/2011; 187(10):5099-113. DOI: 10.4049/jimmunol.1002697
Source: PubMed

ABSTRACT Human Vγ2Vδ2 T cells monitor isoprenoid metabolism by recognizing (E)-4-hydroxy-3-methyl-but-2-enyl pyrophosphate (HMBPP), an intermediate in the 2-C-methyl-d-erythritol-4-phosphate pathway used by microbes, and isopentenyl pyrophosphate (IPP), an intermediate in the mevalonate pathway used by humans. Aminobisphosphonates and alkylamines indirectly stimulate Vγ2Vδ2 cells by inhibiting farnesyl diphosphate synthase (FDPS) in the mevalonate pathway, thereby increasing IPP/triphosphoric acid 1-adenosin-5'-yl ester 3-(3-methylbut-3-enyl) ester that directly stimulate. In this study, we further characterize stimulation by these compounds and define pathways used by new classes of compounds. Consistent with FDPS inhibition, stimulation of Vγ2Vδ2 cells by aminobisphosphonates and alkylamines was much more sensitive to statin inhibition than stimulation by prenyl pyrophosphates; however, the continuous presence of aminobisphosphonates was toxic for T cells and blocked their proliferation. Aminobisphosphonate stimulation was rapid and prolonged, independent of known Ag-presenting molecules, and resistant to fixation. New classes of stimulatory compounds-mevalonate, the alcohol of HMBPP, and alkenyl phosphonates-likely stimulate differently. Mevalonate, a rate-limiting metabolite, appears to enter cells to increase IPP levels, whereas the alcohol of HMBPP and alkenyl phosphonates are directly recognized. The critical chemical feature of bisphosphonates is the amino moiety, because its loss switched aminobisphosphonates to direct Ags. Transfection of APCs with small interfering RNA downregulating FDPS rendered them stimulatory for Vγ2Vδ2 cells and increased cellular IPP. Small interfering RNAs for isopentenyl diphosphate isomerase functioned similarly. Our results show that a variety of manipulations affecting isoprenoid metabolism lead to stimulation of Vγ2Vδ2 T cells and that pulsing aminobisphosphonates would be more effective for the ex vivo expansion of Vγ2Vδ2 T cells for adoptive cancer immunotherapy.

  • Source
    [Show abstract] [Hide abstract]
    ABSTRACT: The role of γδ T cells in immunotherapy has gained specific importance in the recent years because of their prominent function involving directly or indirectly in the rehabilitation of the diseases. γδ T cells represent a minor population of T cells that express a distinct T cell receptor (TCR) composed of γδ chains instead of αβ chains. Unlike αβ T cells, γδ T cells display a restricted TCR repertoire and recognize mostly unknown non-peptide antigens. γδ T cells act as a link between innate and adaptive immunity, because they lack precise major histocompatibility complex (MHC) restriction and seize the ability to recognize ligands that are generated during affliction. Skin epidermal γδ T cells recognize antigen expressed by damaged or stressed keratinocytes and play an indispensable role in tissue homeostasis and repair through secretion of distinct growth factors. γδ T cell based immunotherapy strategies possess great prominence in the treatment because of the property of their MHC-independent cytotoxicity, copious amount of cytokine release, and a immediate response in infections. Understanding the role of γδ T cells in pathogenic infections, wound healing, autoimmune diseases, and cancer might provide knowledge for the successful treatment of these diseases using γδ T cell based immunotherapy. Enhancing the human Vγ9Vδ2 T cells functions by administration of aminobisphosphonates like zoledronate, pamidronate, and bromohydrin pyrophosphate along with cytokines and monoclonal antibodies shows a hopeful approach for treatment of tumors and infections. The current review summarizes the role of γδ T cells in various human diseases and immunotherapeutic approaches using γδ T cells.
    Frontiers in Immunology 11/2014; 5. DOI:10.3389/fimmu.2014.00571
  • Source
    [Show abstract] [Hide abstract]
    ABSTRACT: Most circulating human gamma delta T cells are Vγ9Vδ2 T cells. Their hallmark is the expression of T cell antigen receptors (TCR) whose γ-chains show a Vγ9-JP (Vγ2-Jγ1.2) rearrangement and are paired with Vδ2-containing δ-chains, a dominant TCR configuration, which until recently seemed to occur in primates only. Vγ9Vδ2 T cells respond to phosphoantigens (PAg) such as (E)-4-Hydroxy-3-methyl-but-2-enyl pyrophosphate (HMBPP), which is produced by many pathogens and isopentenyl pyrophosphate (IPP), which accumulates in certain tumors or cells treated with aminobisphosphonates such as zoledronate. A prerequisite for PAg-induced activation is the contact of Vγ9Vδ2 T cells with cells expressing butyrophilin-3 A1 (BTN3A1). We will first critically review models of how BTN3 might act in PAg-mediated Vγ9Vδ2 T cell activation and then address putative co-evolution of Vγ9, Vδ2, and BTN3 genes. In those rodent and lagomorphs used as animal models, all three genes are lost but a data-base analysis showed that they emerged together with placental mammals. A strong concomitant conservation of functional Vγ9, Vδ2, and BTN3 genes in other species suggests co-evolution of these three genes. A detailed analysis was performed for the new world camelid alpaca (Vicugna pacos). It provides an excellent candidate for a non-primate species with presumably functional Vγ9Vδ2 T cells since TCR rearrangements share features characteristic for PAg-reactive primate Vγ9Vδ2 TCR and proposed PAg-binding sites of BTN3A1 have been conserved. Finally, we analyze the possible functional relationship between the butyrophilin-family member Skint1 and the γδ TCR-V genes used by murine dendritic epithelial T cells (DETC). Among placental mammals, we identify five rodents, the cow, a bat, and the cape golden mole as the only species concomitantly possessing potentially functional homologs of murine Vγ3, Vδ4 genes, and Skint1 gene and suggest to search for DETC like cells in these species.
    Frontiers in Immunology 12/2014; 5:648. DOI:10.3389/fimmu.2014.00648
  • Source
    [Show abstract] [Hide abstract]
    ABSTRACT: Comment to Santos et al., " Hyper-IgD and periodic fever syndrome: A new MVK mutation (p.R277G) associated with a severe phenotype " Keywords: Mevalonate Kinase Mevalonate Kinase Deficiency Mevalonic aciduria HIDS Periodic fevers Molecular modeling Immune system To the Editor Santos and co-authors report in their article a novel mutation in Mevalonate Kinase (MVK) gene, associated with a severe phenotype of Hyper-IgD/periodic fever syndrome (HIDS). This phenotype is not particularly different from Hyper-IgD syndrome standard pheno-type, apart from being, as said, quite severe even if associated with normal IgA levels. Indeed, the authors reported that the patient, at the age of 2 years, showed increased levels of serum amyloid A, suf-fered from recurrent episodes of fevers every 2–5 weeks for 3–5 days of duration, malaise, hepatosplenomegaly and massive cervical lymphadenopathy. Moreover, during febrile attacks, the patient occasionally suffers from skin rash, arthralgia, abdominal pain and diarrhea. This framework of symptoms lies on the extreme of the typical group of symptoms observed in HIDS. The authors describe for the first time the p.R277G mutation, situated in a crucial site for protein function as the authors explain in their work (Santos et al., 2014). They cannot link severity of symptoms to the mutation, be-cause their " in silico " analysis (made using SIFT and Polyphen-2 al-gorithms, predicting controversial effects of the mutation) is non-conclusive. Therefore, we decided to perform a molecular modeling analysis of p.R277G mutation, considering the wild type (WT) and mutated (MT) forms and estimating the binding free energy be-tween the protein and some of its ligands. Firstly we evaluated the effects of p.R277G mutation on the structure of chain A of Mevalonate Kinase (PDB ID: 2R3V, RefSeq NM_000431.3), performing structure prediction using the I-TASSER server (Zhang, 2008). Restrains were applied to perform protein threading using avail-able X-ray diffraction data with 2.5 Å resolution (Fu et al., 2008). The best model predicted (C-score = 1.46) has a 0.4 Å root-mean-square deviation (RMSD) of atomic position between 2R3V and the p.R277G mutant, indicating that the mutation has not a considerable impact on the overall structure of the protein (Fig. 1A). However, when the hydro-phobic surface is plotted using UCSF Chimera (Pettersen
    Gene 01/2015; DOI:10.1016/j.gene.2015.01.029 · 2.08 Impact Factor

Full-text (2 Sources)

Available from
Jun 5, 2014